Seattle biotech OncoResponse raises $40.6M to create antibody-based treatments for cancer
Clifford Stocks. (OncoResponse Photo) New funding: OncoResponse raised a $40.6M Series C investment round as
Read the full article at contacted.org...
Found and curated by
Comments
Post a Comment